The five-carbon sugar alcohol D-arabinitol (DA) is a metabolite of most pat
hogenic Candida species, in vitro as well as in vivo, and can be determined
by gas chromatography or enzymatic analysis. Endogenous DA and L-arabinito
l (LA) are present in human body fluids, and serum DA and LA increase in re
nal dysfunction. In prospective clinical studies, elevated DA/LA or DA/crea
tine ratios in serum or urine have been found in immunocompromised, usually
neutropenic, patients with invasive candidiasis. In addition, positive DA
results have been obtained several days to weeks before positive blood cult
ures, and the normalization of DA levels has been correlated with therapeut
ic response in both humans and animals. However, to date, only a few prospe
ctive studies have been conducted in which adequate analytical methods were
used. Thus, further investigation of various patient groups is needed to e
stablish the applicability of the 'arabinitol method' in the diagnostic bat
tery for invasive Candida infections.